Efficacy of imipenem in experimental group B streptococcal bacteremia and meningitis

Research output: Contribution to journalArticle

Abstract

We evaluated the activity of imipenem (N-formimidoyl thienamycin) against a type III group B streptococcal strain in vitro and in vivo. The minimal inhibitory and bactericidal concentrations of imipenem were 15 mg/l. In vivo studies using an infant rat model of group B streptococcal bacteremia and meningitis revealed that imipenem was highly effective. This was shown by (1) rapid bacterial clearance from the blood and cerebrospinal fluid; (2) rapid sterilization of the blood and cerebrospinal fluid; (3) prevention of the development of meningitis in bacteremic animals, and (4) reduction in mortality. Even 10 mg/kg of imipenem produced the mean serum bactericidal titers > 1:100 and cerebrospinal fluid bactericidal titers ≥ 1:16 at 1-2 h after subcutaneous administration. These findings suggest that the activity of imipenem is bactericidal in vitro and in vivo and may be an effective regimen against group B streptococci in this experimental model of bacteremia and meningitis.

Original languageEnglish (US)
Pages (from-to)304-309
Number of pages6
JournalChemotherapy
Volume31
Issue number4
StatePublished - 1985
Externally publishedYes

Fingerprint

Imipenem
Bacteremia
Meningitis
Cerebrospinal Fluid
Streptococcus agalactiae
Theoretical Models
Mortality
Serum
In Vitro Techniques

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Efficacy of imipenem in experimental group B streptococcal bacteremia and meningitis. / Kim, Kwang Sik.

In: Chemotherapy, Vol. 31, No. 4, 1985, p. 304-309.

Research output: Contribution to journalArticle

@article{4dba0ff8adda46d59afc4bfd6b65d081,
title = "Efficacy of imipenem in experimental group B streptococcal bacteremia and meningitis",
abstract = "We evaluated the activity of imipenem (N-formimidoyl thienamycin) against a type III group B streptococcal strain in vitro and in vivo. The minimal inhibitory and bactericidal concentrations of imipenem were 15 mg/l. In vivo studies using an infant rat model of group B streptococcal bacteremia and meningitis revealed that imipenem was highly effective. This was shown by (1) rapid bacterial clearance from the blood and cerebrospinal fluid; (2) rapid sterilization of the blood and cerebrospinal fluid; (3) prevention of the development of meningitis in bacteremic animals, and (4) reduction in mortality. Even 10 mg/kg of imipenem produced the mean serum bactericidal titers > 1:100 and cerebrospinal fluid bactericidal titers ≥ 1:16 at 1-2 h after subcutaneous administration. These findings suggest that the activity of imipenem is bactericidal in vitro and in vivo and may be an effective regimen against group B streptococci in this experimental model of bacteremia and meningitis.",
author = "Kim, {Kwang Sik}",
year = "1985",
language = "English (US)",
volume = "31",
pages = "304--309",
journal = "Chemotherapy",
issn = "0009-3157",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Efficacy of imipenem in experimental group B streptococcal bacteremia and meningitis

AU - Kim, Kwang Sik

PY - 1985

Y1 - 1985

N2 - We evaluated the activity of imipenem (N-formimidoyl thienamycin) against a type III group B streptococcal strain in vitro and in vivo. The minimal inhibitory and bactericidal concentrations of imipenem were 15 mg/l. In vivo studies using an infant rat model of group B streptococcal bacteremia and meningitis revealed that imipenem was highly effective. This was shown by (1) rapid bacterial clearance from the blood and cerebrospinal fluid; (2) rapid sterilization of the blood and cerebrospinal fluid; (3) prevention of the development of meningitis in bacteremic animals, and (4) reduction in mortality. Even 10 mg/kg of imipenem produced the mean serum bactericidal titers > 1:100 and cerebrospinal fluid bactericidal titers ≥ 1:16 at 1-2 h after subcutaneous administration. These findings suggest that the activity of imipenem is bactericidal in vitro and in vivo and may be an effective regimen against group B streptococci in this experimental model of bacteremia and meningitis.

AB - We evaluated the activity of imipenem (N-formimidoyl thienamycin) against a type III group B streptococcal strain in vitro and in vivo. The minimal inhibitory and bactericidal concentrations of imipenem were 15 mg/l. In vivo studies using an infant rat model of group B streptococcal bacteremia and meningitis revealed that imipenem was highly effective. This was shown by (1) rapid bacterial clearance from the blood and cerebrospinal fluid; (2) rapid sterilization of the blood and cerebrospinal fluid; (3) prevention of the development of meningitis in bacteremic animals, and (4) reduction in mortality. Even 10 mg/kg of imipenem produced the mean serum bactericidal titers > 1:100 and cerebrospinal fluid bactericidal titers ≥ 1:16 at 1-2 h after subcutaneous administration. These findings suggest that the activity of imipenem is bactericidal in vitro and in vivo and may be an effective regimen against group B streptococci in this experimental model of bacteremia and meningitis.

UR - http://www.scopus.com/inward/record.url?scp=0021857996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021857996&partnerID=8YFLogxK

M3 - Article

C2 - 3896683

AN - SCOPUS:0021857996

VL - 31

SP - 304

EP - 309

JO - Chemotherapy

JF - Chemotherapy

SN - 0009-3157

IS - 4

ER -